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Summary
Aim-objective: Vitamin D deficiency and rickets in developing countries continues to be a major health problem.
Additionally, the increase of cases of rickets in children of some ethnic groups in the United States and European
countries has provided this issue to be updated. Obviously, powerful strategies are necessary to prevent vitamin D
deficiency nation-wide. In 2005, a nationwide prevention program for vitamin D deficiency was initiated,
recommending 400 IU vitamin D per a day.
This study was designed to evaluate the efficacy of the prevention program.
Methods: Eighty-five infants who were recalled as part of the national screening program for congenital
hypothyroidism between February 2010 and August 2010 at Kocaeli University Children’s Hospital were evaluated
in terms of their vitamin D status as well. All babies had been provided with free vitamin D (Cholecalciferol)
solution and recommended to receive 400 IU (3 drops) daily. Information regarding the age at start of
supplementation, the dosage and compliance were obtained from the mothers with face-to-face interview. Serum
25-hydroxy vitamin D (25-OH-D), alkaline phosphatase (AP), parathormone (PTH) levels were measured.
Results: The mean age at which Vitamin D3 supplementation began was 16.5 ± 20.7 (3-120) days. Ninety percent
of cases (n:76) were receiving 3 drops (400 IU) vitamin D3 per day as recommended; 70% of cases (n:59) were
given vitamin D3 regularly, the remainder had imperfect compliance. Among those children who are older than 12
months, only 20% continued vitamin D supplementation. No subject had clinical signs of rickets. The mean 25-OH-
D level was 42,5 ± 25,8 (median: 38.3) ng/ml. Ten subjects (12%) had their serum 25-OH-D levels lower than 20 ng/
ml (6 between 15-20 ng/ml, 3 between 5-15 ng/ml and only one < 5 ng/ml).
Conclusions: 400 U/day vitamin D seems adequate to prevent vitamin D deficiency. However, we believe that the
program for preventing vitamin D deficiency in Turkey, needs to be reinforced to start immediately after birth, and
to continue beyond 1 year of age at 400U regular daily dosage.
Introduction
Vitamin D deficiency rickets has been a common child
health problem in our sunny country with a recently
reported incidence of 6-7% among children at age 0-3
years (1,2). Powerful strategies are necessary to prevent
vitamin D deficiency nation-wide, because of this high
incidence a prevention program to prevent vitamin D
deficiency rickets was initiated across the country (3,4).
Major obstacles in providing vitamin D supplementation
in infants are limited public awareness, the cost of sup-
plementation and limited access to healthcare. In May
2005, a national program (5-year project) was initiated
to overcome those problems. In addition to, a nation-
wide campaign to encourage the entire population, par-
ticularly pregnant and nursing women and infants, to
have adequate sunlight exposure and a curriculum to
train healthcare workers, distribution of vitamin D sup-
plements to every newborn was started throughout
infancy at no financial cost to families through its net-
work of primary care units and maternal-child health
centers. The recommended dose was 400 IU (4). This
campaign resulted in a dramatic decrease in the inci-
dence of vitamin D deficiency rickets in some regions
(5). However, there is inadequate data relating about the
administration and effects on vitamin D levels.
This study was designed to gain insight about the effi-
cacy of the prevention program locally in our region.
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The study was conducted in Kocaeli, a relatively indus-
trialized city in the northeastern part of Turkey. Eighty-
five infants who were referred from the national screen-
ing program for congenital hypothyroidism and need
venous thyroid function assessment, between February
2010 and August 2010 at Kocaeli University Children’s
Hospital were evaluated in terms of their vitamin D sta-
tus as well. This study was approved by Local Ethics
Committee of Kocaeli Health Autority (IAEK 3/13
27.10.2009) and conducted in accordance with the
guidelines of The Declaration of Helsinki. Written
informed consent was obtained from the parents of sub-
jects. (Copies of the written consents are available for
review by the Editor-in-Chief of this journal.) The mean
age was 263 ± 116 days (84-554 days). All babies had
been provided with free vitamin D (Cholecalciferol)
solution (Devit-3 oral solution, Deva, Turkey that con-
tains 133 IU vitamin D3 in one drop) and recommended
to receive 400 IU (3 drops) daily.
Information regarding the age at start of supplementa-
tion, the dosage and compliance were obtained from the
mothers with face-to-face interview. The nutrition style
and sun exposure were not taken in consideration.
Serum 25-hydroxy Intra and inter assay CVs (coefficient
variations) were 2.8% and 3.4% respectively. Vitamin D
(25-OH-D), alkaline phosphatase (AP), parathormone
(PTH) levels were measured. Serum 25-OH-D levels
were analyzed and estimated by ELISA reader and
microelisa method. Intra and inter assay CVs (coefficient
variations) were < 8% and < 10% respectively. Vitamin D
status was classified according to Drug and Therapeutics
Committee of the Lawson Wilkins Pediatric Endocrine
Society (LWEPS) recommendation about cut-off levels
for states of vitamin D (25-OH-D< 5 ng/ml: severe defi-
ciency, 5-15 ng/ml: deficiency, 15-20 ng/ml: insuffi-
ciency, 20-100 ng/ml: sufficiency) (6). Serum AP level
was measured using Abbot Aeroset Autoanalyzer by
spectrophotometric method. The manufacturer’s normal
range for AP was 40-150 U/L, but 145-420 IU/L was
accepted normal range for study group (7). Serum iPTH
was measured using an original assay using Roche Diag-
nostics E-170 Modular Analytics immunoanalyzer
equipment. The manufacturer’s normal range for iPTH
was 15-65 ng/L. Intra and inter assay CVs (coefficient
variations) were 2.8% and 3.4% respectively.
Statistical analyses were performed using SPSS and
student’s t test was used for comparison.
Results
The study group composed of 85 healthy infants (45
girls and 40 boys). The mean birth weight was 3206 ±
53.8 (1370-4680) gr, mean gestational age was 38.8 ±
1.6 (32-42) weeks. The mean age at which Vitamin D3
supplementation began was 16.5 ± 20.7 (3-120) days.
Ninety percent of cases (n:76) were receiving 3 drops
(400 IU) vitamin D3 per day as recommended; 70% of
cases (n:59) were given vitamin D3 regularly, the
remainder had imperfect compliance. Among those chil-
dren who are older than 12 months, only 20% continued
vitamin D supplementation (Table 1).
Seven subjects (8%) were premature. The mean 25-
OH-D level of premature infants was 37.7 ± 10.5 ng/ml
(21.3-50.4 ng/ml).
No subject had clinical signs of rickets. The mean 25-
OH-D level was 42,5 ± 25,8 (median: 38.3) ng/ml. Ten
subjects (12%) had their serum 25-OH-D levels lower
than 20 ng/ml (6 between 15-20 ng/ml, 3 between 5-15
ng/ml and only one < 5 ng/ml) (Table 2). Ninety-three
percent of subjects who reported adequate compliance
had 25-OH-D levels within sufficient range (> 20 ng/ml).
Twenty seven percent of subjects who had sufficient (>
20 ng/ml) 25-OH-D level had reported inadequate com-
pliance. The mean 25-OH-D level of non-compliant sub-
jects’ was 39.6 ± 33 ng/ml (12.9-153 ng/ml). Six out of 10
cases whose 25-OH-D levels were lower than 20 ng/ml
reported irregular consumption. All infants with serum
25-OH-D levels lower than 20 ng/ml had normal AP
levels, while two had elevated PTH levels. As a group,
subjects with serum 25-OH-D levels < 20 ng/ml had sig-
nificantly higher PTH levels compared with those with
vitamin D sufficiency (25-OH-D > 20 ng/ml) (51.6 ± 47.3
pg/ml and 27.2 ± 12 pg/ml respectively, p:0.00). There
was no significant difference in AP levels between those
two groups (Table 3).
Discussion
Vitamin D sources in early infancy consist of transpla-
cental stores, human milk, and cutaneous production
via sunlight. High prevalence of maternal vitamin D
deficiency, insufficient vitamin D content of human
milk, and limited sunlight exposure particularly in the
first six months of life all increase risk of vitamin D
deficiency and rickets. This is particularly important in
infants who are primarily breastfed (8-11). Therefore,
daily supplementation of vitamin D appears to be the
Table 1 Demographic characteristics of cases
Number of cases (n) 85
Gender (Male/Female) 45/40
Age (days) 263 ± 116 (84-554)
Birth weight (g) 3206 ± 53.8 (1370-4680)
Gestation age (weeks) 38.8 ± 1.6 (32-42)
Supplementation starting time (days) 16.5 ± 20.7 (3-120)
Cases older than 12 months taking vitamin D 4 (20%)
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status and prevent rickets in infancy.
Although there is consensus on the need for vitamin
D supplementation, the debate regarding the dose still
continues (12). In the past, there has been conflict on
the timing and dosage of vitamin D supplementation.
European Society for Paediatric Endocrinology (ESPE)
Bone Club recommended that all breast-fed infants,
regardless of skin color or latitude, should receive 400
IU of supplemental vitamin D per day from birth until
they are receiving adequate formula or vitamin D-forti-
fied cow’s milk to provide 400 IU of vitamin D per day,
in 2002 (13). Nonetheless, American Academy of Pedia-
trics (AAP) had recommended 200 U/day vitamin D
supplementation in 2003 and this recommendation of
AAP influenced pediatricians’ approach to vitamin D
supplementation worldwide (14). Beginning vitamin D
supplementation from firstm o n t hw a sa c c e p t e da tt h e
time. However, in geographic areas where maternal vita-
min D deficiency is endemic, infantile serum 25-OH-D
levels were rickets in breastfed infants in US and other
developed decreased < 10 ng/ml earlier than one month
(15). Considering the increased incidence of countries,
AAP made a new recommendation suggesting 400 U/
day vitamin D from the first days of life (6).
Today, it is considered that daily 400 U supplementa-
tion of vitamin D is adequate to provide serum 25OH-D
level > 12 ng/ml in almost all infants and > 20 ng/ml in
the majority of infants (6,11). However, some countries
such as Canada continues 800 U vitamin D supplemen-
tation per day between December and April (16). There
are few studies suggesteing that 400 U is inadequate
(17). The results of the current study suggest that daily
vitamin D supplementation of 400 U is sufficient to
establish serum 25-OH-D levels > 20 ng/ml (vitamin D
sufficiency) in great majority of infants if they receive it
regularly. It is noteworthy that daily vitamin D
supplementation of 400 U appears to prevent rickets
even among those infants receiving the supplementation
in an irregular manner. We conclude that 400 U/day
vitamin D supplementation seems sufficient in Turkey,
even in a country where maternal vitamin D deficiency
rate is as high as 80% (18-20). These results also support
an earlier study reporting dramatic decrease in the inci-
dence of rickets in the Erzurum area following the men-
tioned program (5). Four infant have 25-OHD levels >
100 ng/ml; Unfortunately we do not have information
to explain vitamin D excess. It may be related to vitamin
D fortified formula feeding, but we do not know their
nutrition type.
Despite strong nationwide strategies continous moni-
toring of vitamin D intake of infants, i.e. administration
via mother is also mandatory. Surprisingly, there is no
preventive strategy in United Kingdom where a resur-
gence of vitamin D deficiency and rickets in the peadia-
tric population (3). An effective vitamin D
supplementation programme does exists in Canada.
However, it is reported that 30% of mothers do not give
400 U/day vitamin D on account of feeding their babies
with formula (21). Also it is observed that 30% of
mothers had not given their babies 400 U/day vitamin
D regularly in our study.
In conclusion, we believe that the program for pre-
venting vitamin D deficiency in Turkey, needs to be
reinforced to start immediately after birth, and to con-
tinue beyond 1 year of age at 400 U regular daily
dosage. Nevertheless, othero p t i o n ss u c ha sh i g hd o s e
vitamin D supplementations for mothers, particularly
during lactation should also be encountered. It is needed
more comprehensive studies to conclude that daily 400
U vitamin D is sufficient for term and also preterm
babies.
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